T

TNXP

Tonix Pharmaceut

17.02

2.06+13.77%
After Hours: 16.79  -0.23  -1.35%19:58 04/23 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Cash from Operating Activities

-60.92M

-102.00M

-98.05M

-75.56M

-48.57M

Net Income

-130.04M

-116.66M

-110.22M

-92.29M

-50.46M

Depreciation/Depletion & Amortization

3.42M

4.29M

1.25M

50.00K

27.00K

Deferred Taxes

--

--

--

--

--

Non-Cash Items

59.91M

10.40M

10.91M

10.90M

4.24M

Changes in Working Capital

5.78M

-35.00K

-2.00K

5.78M

-2.37M

Cash from Investing Activities

-120.00K

-29.07M

-48.15M

-35.31M

-8.56M

Capital Expenditures

-120.00K

-7.89M

-48.15M

-35.31M

-8.56M

Other Investing Cash Flow Items, Total

--

-21.18M

--

--

--

Cash from Financing Activities

134.87M

36.52M

87.84M

212.49M

123.11M

Financing Cash Flow Items

-3.00M

--

--

--

--

Total Cash Dividends Paid

--

--

--

--

--

Issuance (Retirement) of Stock, Net

140.22M

27.57M

87.84M

212.49M

123.11M

Issuance (Retirement) of Debt, Net

-2.35M

8.94M

--

--

--

Foreign Exchange Effects

4.00K

-65.00K

-74.00K

-31.00K

-16.00K

Net Change in Cash

73.83M

-94.62M

-58.43M

101.59M

65.96M

Cash Interest Paid

1.23M

--

--

--

--

Cash Taxes Paid

--

--

--

--

--